Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
PubMed laboratory research record [PMID: 38094687] PubMed record related to this compound for laboratory literature review
FDA approval, if granted, would likely occur in late 2026 or early 2027 based on typical review timelines
Extracellular vesicles are associated with Creactive protein in sepsis
142 In addition, ERAD directly restrains hepatic lipogenesis by targeting ATP-citrate lyase (Acly), a key enzyme that channels citrate toward fatty acid synthesis
Blood 2007
- , - ,
US$ 25.37
US$ 21.91
US$ 24.51
US$ 25.67
US$ 29.33
US$ 22.58
